This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muller, M T Articles by Mehta, V B Search for Related Content PubMed PubMed Citation Articles by Muller, M T Articles by Mehta, V B

DNase I hypersensitivity is independent of endogenous topoisomerase II activity during chicken erythrocyte differentiation.

Department of Molecular Genetics, Ohio State University, Columbus 43210.

ABSTRACT

Endogenous topoisomerase II cleavage sites were mapped in the chicken beta A-globin gene of 12- to 14-day embryonic erythrocytes. A major topoisomerase II catalytic site was mapped to the 5' end of the globin gene which contained a nucleosome-free and DNase I-hypersensitive site and additional but minor sites were mapped to the second intron and 3' of the gene to a tissue-specific enhancer. Cleavage sites, mapped in situ by indirect end labeling, were aligned to single-base-pair resolution by comparison to a consensus sequence derived for vertebrate topoisomerase II catalytic sites. In contrast to embryonic erythrocytes, endogenous topoisomerase II cleavages were not detected in erythrocytes from peripheral blood of adult chickens; therefore, as the transcriptional activity of the beta A-globin gene declines during terminal differentiation of erythrocytes, the activity of topoisomerase II in situ declines as well, despite the fact that DNase I hypersensitivity persists. The results showed that DNase I-hypersensitive chromatin can be maintained in the absence of topoisomerase II activity and suggested that topoisomerase II acts at hypersensitive sites because of an inherent attraction to some preexisting combination of DNA sequence or chromatin structure associated with DNase I-hypersensitive regions.

This article has been cited by other articles:

• Adachi, N., So, S., Koyama, H. (2004). Loss of Nonhomologous End Joining Confers Camptothecin Resistance in DT40 Cells: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE I-MEDIATED DNA DAMAGE. J. Biol. Chem. 279: 37343-37348 [Abstract] [Full Text]  
• Kang, M. R., Muller, M. T., Chung, I. K. (2004). Telomeric DNA Damage by Topoisomerase I: A POSSIBLE MECHANISM FOR CELL KILLING BY CAMPTOTHECIN. J. Biol. Chem. 279: 12535-12541 [Abstract] [Full Text]  
• Martinez, E. J., Owa, T., Schreiber, S. L., Corey, E. J. (1999). Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. Proc. Natl. Acad. Sci. USA 96: 3496-3501 [Abstract] [Full Text]  
• Tsutsui, K., Tsutsui, K., Sano, K., Kikuchi, A., Tokunaga, A. (2001). Involvement of DNA Topoisomerase IIbeta in Neuronal Differentiation. J. Biol. Chem. 276: 5769-5778 [Abstract] [Full Text]